Related Experiment Video
Updated: Jul 4, 2026
07:25
Driving Under the Influence: How Music Listening Affects Driving Behaviors
Published on: March 27, 2019
[Driving ability under opioids: current assessment of published studies]
1Universitäts Schmerz Centrum, Klinik für Anästhesiologie, Universitätsklinikum Carl Gustav Carus, Dresden. rainer.sabatowski@uniklinikum-dresden.de
Deutsche Medizinische Wochenschrift (1946)
|July 2, 2008
Summary
Stable opioid pain treatment may not impair driving ability. Studies show patients on fentanyl or buprenorphine performed better than legally intoxicated individuals, but more research is needed for definitive conclusions on driving safety.
Area of Science:
- Pain Management
- Pharmacology
- Neuroscience
Context:
- Opioids are increasingly prescribed for chronic non-cancer pain.
- Patient reintegration into social activities, including driving, is a key treatment goal.
- Assessing opioid impact on driving ability is crucial for patient safety and quality of life.
Purpose:
- To evaluate the effect of sustained opioid therapy on driving performance in chronic pain patients.
- To compare the driving capabilities of patients on transdermal fentanyl or buprenorphine with legal alcohol impairment limits.
Summary:
- Two studies investigated opioid effects on driving.
- Patients with chronic pain on sustained transdermal fentanyl or buprenorphine treatment performed better than healthy individuals at a blood alcohol concentration of 0.05%.
- Current evidence suggests stable opioid treatment may not inherently impair driving ability, but does not confirm unrestricted driving safety.
Impact:
- Findings suggest that some patients on stable opioid therapy might be able to drive safely.
- Highlights the need for further research to establish clear guidelines for driving while on opioid medication.
- Informs clinical practice regarding patient counseling on driving risks associated with opioid use for chronic pain.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:28Depressants
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...